Hubert C Chen
Chief Medical Officer at Viking Therapeutics, Inc. (VKTX) since June 2026
Hubert C Chen has filed 12 insider reports with the SEC since February 2021, as chief Medical Officer at Viking Therapeutics, Inc. (VKTX), officer at Forte Biosciences, Inc. (FBRX) and officer at Metacrine, Inc. (MTCR). Hubert C Chen made no open-market purchases or sales in the last 12 months. The latest filing, on June 3, 2026, reports grant or award at Viking Therapeutics, Inc. (VKTX).
- Filings
- 12
- Companies
- 3
- Bought on market
- $11.8K
- Sold on market
- None
Companies where Hubert C Chen is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Chief Medical Officersince June 2026 | $26.17 | Jun 3, 2026 | |||||
| Officersince June 2022 | 93,405 | Jan 3, 2024 | |||||
| Officer | 3,289 | $11.8K | $3.60 | May 20, 2021 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- Jun 1, 2026VKTXSEC Form 4 filed by Chief Medical Officer Chen Hubert CForm 4Grant or award
- Jun 1, 2026VKTXHubert C Chen became an insiderForm 3New insider
- Jan 1, 2024FBRXChen Hubert C converted options into 7,500 shares and covered exercise/tax liability with 3,073 shares, increasing direct ownership by 5% to 93,405 unitsForm 4Shares withheld for taxes or exercise priceExercise or conversion of a derivative
- Oct 1, 2023FBRXChen Hubert C converted options into 7,500 shares and covered exercise/tax liability with 2,593 shares, increasing direct ownership by 6% to 88,978 unitsForm 4Shares withheld for taxes or exercise priceExercise or conversion of a derivative
- Jul 31, 2023FBRXSEC Form 4: Chen Hubert C was granted 74,257 shares, increasing direct ownership by 757% to 84,071 unitsForm 4Grant or award
- Jul 1, 2023FBRXSEC Form 4 filed by Chen Hubert CForm 4Shares withheld for taxes or exercise priceExercise or conversion of a derivative
- Apr 1, 2023FBRXSEC Form 4 filed by Chen Hubert CForm 4Shares withheld for taxes or exercise priceExercise or conversion of a derivative
- Feb 25, 2023FBRXSEC Form 4 filed by Chen Hubert CForm 4Grant or award
- Jun 7, 2022FBRXSEC Form 4 filed by Chen Hubert CForm 4Grant or award
- Jun 7, 2022FBRXHubert C Chen became an insiderForm 3New insider
- May 20, 2021+$11.8KMTCRSEC Form 4: Chen Hubert C bought $11,840 worth of Common Stock (3,289 units at $3.60)Form 4Open-market purchase
- Feb 10, 2021MTCRSEC Form 4 filed by C Hubert ChenForm 4Grant or award
Compare Hubert C Chen with
- Hubert C Chen vs Steven Kornfeld1 shared
- Hubert C Chen vs Scott C. Brun1 shared
- Hubert C Chen vs David W Gryska1 shared
- Hubert C Chen vs Richard G Vincent1 shared
- Hubert C Chen vs Barbara K Finck1 shared
- Hubert C Chen vs Shivpreet Singh Kapoor1 shared
Other insiders at the same companies
- Steven KornfeldFBRX
- Scott C. BrunFBRX
- David W GryskaFBRX
- Richard G VincentFBRX
- Barbara K FinckFBRX
- Shivpreet Singh KapoorFBRX
- Stephen K DobersteinFBRX
- Antony A RileyFBRX
- Paul A. WagnerFBRX
- Dorothy Elizabeth Kelly-GemmellVKTX
- Brian LianVKTX
- Greg ZanteVKTX
- Marianna ManciniVKTX
- Neil William AubuchonVKTX
- J Matthew SingletonVKTX
- Lawson MacartneyVKTX
Questions about Hubert C Chen
- What is Hubert C Chen's role at Viking Therapeutics, Inc.?
- Hubert C Chen reports to the SEC as chief Medical Officer at Viking Therapeutics, Inc. (VKTX), according to the latest filing on June 3, 2026. Hubert C Chen has also filed as officer at Forte Biosciences, Inc. (FBRX) and officer at Metacrine, Inc. (MTCR).
- How many shares does Hubert C Chen own?
- After the latest filing that states it, Hubert C Chen directly owned 93,405 shares of Forte Biosciences, Inc. (FBRX) and 3,289 shares of Metacrine, Inc. (MTCR). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Hubert C Chen bought or sold stock recently?
- The most recent open-market purchase was on May 20, 2021: bought 3,289 shares of Metacrine, Inc. (MTCR) for $11.8K at an average of $3.60.
- How do I get alerts when Hubert C Chen files?
- Follow Hubert C Chen on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by Hubert C Chen (SEC CIK 0001622297). Totals count each trade once, skipping amendments whose original is on file, from Feb 12, 2021 on. View on SEC EDGAR